Ciprofol is a novel 2,6-disubstituted phenol derivatives and is proved have much higher potency and tighter binding toward ɣ-aminobutyric acid type A (GABAA) receptor while maintaining a fast on-set and recovery time compared to propofol. Except lower incidence of hypotension and respiratory depression, it has no injection pain and infusion syndrome compared with propofol. There is no study to investigate overall postoperative functional recovery in patients receiving total intravenous anesthesia (TIVA) using ciprofol yet. However, according to study, early quality of recovery according to QoR-15 score is associated with one-month postoperative complications after elective surgery. Therefore, the purpose of this study is to determine whether there is any difference in the quality of postoperative recovery between ciprofol-based and propofol-based TIVA in elderly patients undergoing gastrointestinal surgery. The QoR-15 questionnaire score, pain, nausea/vomiting, and the frequency of complications are evaluated and compared between the two groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
280
Xijing Hospital
Xi'an, Shaanxi, China
NOT_YET_RECRUITINGXijing Hospital
Xi'an, Shaanxi, China
RECRUITINGQuality of Recovery(QoR)-15 questionnaire score at postoperative day 1
Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 1(minimum value: 0, maximum value: 150, the higher the score, the better the result)
Time frame: Postoperative day 1
Quality of Recovery(QoR)-15 questionnaire score at postoperative day 2
Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 2 (minimum value: 0, maximum value: 150, the higher the score, the better the result)
Time frame: Postoperative day 2
Incidence of injection pain
Record the incidence of injection pain ( yes or no)
Time frame: during anesthesia induction
Hemodynamic change
Record the mean arterial pressure (MAP) at different points, including before induction, after induction, immediately after intubation, at the beginning of surgery, at the end of anesthesia, immediately after extubation, and before leaving the room
Time frame: During the operation
Vasoactive agents
Percentage of patients needed vasoactive agents during anesthesia
Time frame: from start of surgery to end of surgery
Tracheal extubation time
Time from cessation of main anaesthetics to tracheal extubation
Time frame: From stopping ciprofol or propofol infusion to awake and withdrawal of tracheal tube, approximately 30 minutes
Postoperative sedation score
Monitored by the sedation scale called Sedation-Agitation Scale (SAS). SAS is a medical scale used to measure the agitation or sedation level of a person.The score ranges from 1 to 7
Time frame: Immediately after awake,approximately 1 hour after surgery
Postoperative pain score
postoperative pain score measured by 11-point VAS (Visual Analogue Scale) score (minimum : 0, maximum : 10, the lower the score, the lesser pain)
Time frame: Immediately after awake, approximately 1 hour after surgery
Postoperative nausea and vomiting
Postoperative nausea and vomiting will be evaluated by PONV (Post Operative Nausea And Vomiting) score (no : 0, vomit: 4)
Time frame: Immediately after awake, approximately 1 hour after surgery
First exhaust time
Record the first exhaust time After the operation
Time frame: 24 hours after end of surgery, approximately 24 hours
Hospital stay
days of hospital stay
Time frame: From end of surgery to discharge from hospital, on an average of 7 days
Postoperative complications
Various complications occurred during hospitalization
Time frame: From end of surgery to discharge from hospital, on an average of 7 days
Adverse event
Percentage of adverse events occurred during hospitalization
Time frame: From end of surgery to discharge from hospital, on an average of 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.